The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
Table 2
General characteristic and biomarkers in patients with various severities.
Variables
Severe patients ()
Moderate patients ()
Mild patients ()
Age (year)
34.50 (22.00–46.50)
28.00 (24.00–42.00)
31.50 (23.00–45.00)
Gender (male/female)
4/11
7/19
0/10
(pg/mL)
1134.80 (1088.99–2273.87)
1183.00 (510.08–2048.48)Δ
631.4 (521.35–1049.26)♦♦
(pg/mL)
18.84 (13.10–39.31)
23.85 (11.70–28.25)
20.12 (15.40–23.76)
(pg/mL)
11.08 (5.24–22.28)
8.55 (2.96–22.51)
3.03 (2.27–11.23)
(pg/mL)
140.08 (57.29–648.21)
171.79 (57.00–314.95)
35.02 (22.28–100.79)
D-dimer (ug/L)
3865.00 (1235.00–7820.00)
2225.00 (850.00–65510.00)
935.00 (580.00–3360.00)♦
(ng/mL)
530.88 (429.76–743.62)
457.08 (326.90–602.43)
442.92 (289.52–705.80)
(g/L)
11.06 (10.94–11.06)
10.86 (10.58–10.86)Δ
12.63 (12.20–12.63)
(g/L)
2.15 (2.15–2.15)
2.05 (1.88–2.05)Δ
1.93 (1.93–2.04)
(g/L)
1.13 (1.13–1.13)
1.40 (1.21–1.40)ΔΔ
1.43 (1.43–1.51)
(g/L)
0.84 (0.83–0.84)
0.97 (0.90–0.97)ΔΔ
1.01 (0.95–1.11)
(g/L)
0.20 (0.20–0.21)
0.20 (0.18–0.20)
0.21 (0.20–0.22)
ESC (mm/h)
13.25 (3.37–46.55)
11.55 (3.25–27.60)ΔΔ
7.10 (2.07–13.50)♦♦
CRP (mg/L)
12.00 (8.50–12.75)
17.67 (12.75–17.75)
7.25 (7.19–7.44)
(/L)
11.49 (8.02–13.15)
8.99 (6.37–10.62)
7.55 (6.24–10.12)♦
(/L)
0.06 (0.01–0.10)
0.07 (0.03–0.15)
0.10 (0.04–0.14)
(/L)
4.47 (4.05–4.73)
4.40 (4.14–4.54)
4.32 (4.05–4.94)
(g/L)
126.00 (113.50–136.50)
130.00 (125.00–135.00)
126.50 (115.00–141.00)
(/L)
235.00 (193.50–303.50)
244.00 (209.00–308.00)
269.50 (243.00–320.00)
(mmol/L)
5.39 (4.84–5.67)
5.28 (4.84–5.57)
5.13 (4.90–5.65)
CCL, chemokine ligand; Ig, immunoglobulin; C3, complement 3; C4, complement 4; ESR, erythrocyte sedimentation rate; WBC, white blood cell; Eo, eosinophil; RBC, red blood cell; PLT, platelet; Glu, glucose; CRP, C-reactive protein. and when severe group compared with moderate group. and when severe group compared with mild group. and when moderate group compared with mild group.
